Investors with a lot of money to spend have taken a bearish stance on Amgen AMGN. And retail traders should know. We noticed this today when the trades showed up on publicly available options ...

Fueled by upbeat management comments on an experimental obesity treatment, Amgen’s stock was on pace early Friday for its best day since 2009 — and analysts see more gains ahead as the company ...

Amgen's stock price remains nearly unchanged over 1.5 years, but its valuation may now be more reasonable or even a bargain. Despite high debt from the Horizon Therapeutics acquisition, Amgen ...